Related Experiment Videos
Erotomania : epidemiology and management
1Department of Adult Psychiatry, University College Dublin, Mater Misericordiae University Hospital, Dublin, Ireland. brendankelly35@gmail.com
CNS Drugs
|August 16, 2005
Summary
Erotomania, a delusional disorder, is being studied for its causes and treatments. Research shows atypical antipsychotics may improve outcomes compared to older medications, but more trials are needed.
Area of Science:
- Psychiatry
- Neuroscience
Background:
- Erotomania is classified as a delusional disorder.
- Its incidence is unknown, but delusional disorder affects ~15 per 100,000 annually.
- It presents in primary and secondary forms, with secondary linked to other conditions.
Purpose of the Study:
- To review the understanding and management of erotomania.
- To highlight advancements in treatment and identify future research needs.
Main Methods:
- Review of existing literature on erotomania classification, etiology, and treatment.
- Discussion of pharmacological and psychosocial interventions.
- Examination of neuroimaging, genetic, and evolutionary psychopathology findings.
Main Results:
- Secondary erotomania management targets underlying conditions.
- Primary and secondary erotomania treatment combines medication, psychosocial interventions, and risk management.
- Atypical antipsychotics (risperidone, clozapine) show promise over older drugs like pimozide due to better tolerability.
Conclusions:
- Further controlled clinical trials are essential for optimizing therapeutic strategies for primary erotomania.
- Understanding the etiology of primary erotomania may be advanced by neuroimaging and genetic studies.
- Improved patient outcomes may result from better tolerability of newer antipsychotic medications.